MedPath

Clinical evaluation of the effect of oral administration of the classical siddha drug vÄ?tarÄ?ká¹£aca kulikai along with external Ä?raá¹?á¹­a tailam therapy in the management of special child

Phase 2
Conditions
Health Condition 1: G809- Cerebral palsy, unspecified
Registration Number
CTRI/2019/08/020510
Lead Sponsor
Geethasre Balaji
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
21
Inclusion Criteria

The patient attending to the OPD of Kuzhanthai maruthuvam department will be screened for the following symptoms

Primary symptoms

1. delayed milestones especially delay in the motor development.

2. The patient will also be assessed according to the Gross Motor Function Classification System- Not more than Level 3

Manual Ability Classification System- not more than level 4

by this stiffness and weakness of the muscles will be assessed.

Exclusion Criteria

Cerebral Palsy with severe seizures

Cerebral Palsy with associated Congenital Disorders

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. GMFCS level (Gross Motor Function Classification System) for Mobility <br/ ><br>2. FSST (Four Square Step Test) <br/ ><br>3. TUG(Timed up and Go Test) <br/ ><br>4. MAS(Modified Ashworth Scale) <br/ ><br>5. CFCS(Communication Function Classification System) for communication. <br/ ><br>6. MACS (Manual Ability Classification System)Timepoint: 1 month
Secondary Outcome Measures
NameTimeMethod
Cognitive SkillsTimepoint: 3 Months
© Copyright 2025. All Rights Reserved by MedPath